Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06383988 · ClinicalTrials.gov registry record · NA

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

A NA study of Stage IV Lung Cancer and Stage II Lung Cancer, sponsored by Wake Forest University Health Sciences.

Active
Registry status
NA
Development phase
216
Enrollment target
20
Study locations

NCT06383988: Active NA study of Stage IV Lung Cancer and Stage II Lung Cancer, sponsored by Wake Forest University Health Sciences.

NCT06383988 is a NA study of Stage IV Lung Cancer and Stage II Lung Cancer that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 216 participants, above the 136-participant average among 5 other Stage IV Lung Cancer trials with a reported enrollment target (59% higher). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06383988, a NA study of Stage IV Lung Cancer and Stage II Lung Cancer, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
216 participants
Enrollment target
20
Study locations

Study Summary

Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.

Primary Outcome

Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval.

Interventions

  • BEHAVIORAL Patient Navigation
  • OTHER Support for Caregiver - Generic List
  • OTHER Support for Caregiver - Personalized List
  • OTHER Internet-Based Intervention - CONNECT

Study Locations (20)

South Carolina

  • Gibbs Cancer Center-Gaffney - Gaffney
  • Prisma Health Cancer Institute - Butternut - Greenville
  • Prisma Health Cancer Institute - Eastside - Greenville
  • Gibbs Cancer Center-Pelham - Greer
  • Spartanburg Medical Center - Spartanburg
  • MGC Hematology Oncology-Union - Union

Colorado

  • Kaiser Permanente-Franklin - Denver
  • Kaiser Permanente - Rock Creek - Lafayette
  • Kaiser Permanente - Lone Tree - Lone Tree

Delaware

  • Beebe South Coastal Health Campus - Millville
  • Beebe Health Campus - Rehoboth Beach

Hawaii

  • Hawaii Cancer Care Inc - Waterfront Plaza - Honolulu
  • Hawaii Cancer Care - Westridge - ‘Aiea

Missouri

  • Lake Regional Hospital - Osage Beach
  • CoxHealth South Hospital - Springfield

Pennsylvania

  • Community Medical Center - Scranton
  • Geisinger Wyoming Valley/Henry Cancer Center - Wilkes-Barre

Georgia

  • Augusta University Medical Center - Augusta

New York

  • Montefiore Medical Center-Einstein Campus - The Bronx

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2024-11-11
Est. Completion 2026-07-30
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the registry record for NCT06383988 still lists

NCT06383988 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, above the 136-participant average among 5 other Stage IV Lung Cancer trials with a reported enrollment target (59% higher).

The record links to 3 conditions, with Stage IV Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Patient Navigation is the first listed.

NCT06383988 names 20 study sites across 9 states, led by South Carolina, Colorado, Delaware.

Frequently Asked Questions

What is clinical trial NCT06383988 about?

NCT06383988 is a clinical study titled "A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources". Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community o...

What is the current status of trial NCT06383988?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2024-11-11. Estimated completion is 2026-07-30.

What conditions does trial NCT06383988 study?

This clinical trial studies the following conditions: Stage IV Lung Cancer, Stage II Lung Cancer, Stage III Lung Cancer.

What interventions are being tested in trial NCT06383988?

The interventions under investigation include: Patient Navigation (BEHAVIORAL), Support for Caregiver - Generic List (OTHER), Support for Caregiver - Personalized List (OTHER), Internet-Based Intervention - CONNECT (OTHER).

Who is sponsoring clinical trial NCT06383988?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06383988 being conducted?

This trial has 20 study locations across Colorado, Delaware, Georgia, Hawaii, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stage IV Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06383988, the US trial registry maintained by the National Library of Medicine. NCT06383988 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.